Drugs and Aging

SJR Rank #2,934H-index: 119SJR: 1.354Best quartile: Q1APC: US$4,990
Journal website: aims, scope and author guidelines
Publisher

Country

Switzerland

Type

journal

SJR by Edition

2022202500.350.71.051.4

Subject Categories

  • Geriatrics and GerontologyQ1
  • Pharmacology (medical)Q1

Areas: Medicine

Most published research topics

Pharmaceutical Practices and Patient OutcomesMedication Adherence and ComplianceDementia and Cognitive Impairment ResearchBlood Pressure and Hypertension StudiesHealth Systems, Economic Evaluations, Quality of LifeHeart Failure Treatment and ManagementFrailty in Older AdultsIntensive Care Unit Cognitive DisordersPain Management and Opioid UseAtrial Fibrillation Management and Outcomes

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs065130195260

Documents per Year

202220250255075100

Detailed Information

ISSN

1170-229X, 1179-1969

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

4.50

References per Document

63.73

Coverage

1991-2026

Scope

Drugs & Aging promotes optimum drug therapy in older adults through a program of review and original research articles covering aspects of clinical pharmacology and patient management in this important patient population. The Journal includes: Leading/current opinion articles providing an overview of contentious or emerging issues. Definitive reviews of drugs and drug classes and their place in the management of disease. Therapy in Practice reviews including recommendations for specific clinical situations. Adis Drug Evaluations reviewing the properties and place in therapy of both newer and established drugs. High quality, well designed original research with a strong link to clinical practice. Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in Drugs & Aging may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand important medical advances.

Metrics from SCImago Journal Rank 2025. View on SCImago